Recent ENVB News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 10:58:26 PM
- Enveric Biosciences to Participate in BIO International Convention 2024 • Business Wire • 05/30/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 08:15:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 12:00:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 09:25:22 PM
- Enveric Biosciences Reports First Quarter 2024 Financial and Corporate Results • Business Wire • 05/15/2024 10:00:00 AM
- Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health Disorders • Business Wire • 05/14/2024 12:00:00 PM
- Enveric Biosciences Announces Signing of Non-Binding Term Sheet with Undisclosed Licensee for Exclusive License to Patented Methods of Treating Breast and Other Cancers Using Cannabinoids • Business Wire • 05/08/2024 11:00:00 AM
- Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023 • Business Wire • 03/26/2024 11:00:00 AM
- Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease • Business Wire • 03/19/2024 11:00:00 AM
- Enveric Biosciences Announces New Patent Issuances Protecting Multiple Assets Covered by Non-Binding Term Sheets • Business Wire • 03/12/2024 11:00:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/11/2024 04:35:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 12:00:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:00:24 PM
- Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of Three Classes of Compounds • Business Wire • 02/29/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:53:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:47:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:42:03 PM
- Enveric Biosciences Agrees to Sell Cancer-Targeting Cannabinoid-Related Intellectual Property • Business Wire • 02/23/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 01:05:30 PM
- Enveric Biosciences Unveils Library of Preclinical Compounds Across Multiple Distinct Molecule Classes Targeting Mental Health Disorders • Business Wire • 02/21/2024 01:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:36:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 01:05:27 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 03:17:24 PM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM